Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KYTX

Kyverna Therapeutics Inc

May 11 • 04:00PM ET

10.34

+0.99 10.59 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CABA RNAC CRBU FATE SANA

| Held by: VTI VXF IBB SCHA DWAS SURI IWC AVSC PRFZ DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.66	Insider Own	38.00%	Shs Outstand	60.39M	Perf Week	14.89%
Market Cap	625.89M	Forward P/E	-	EPS next Y	-2.98	Insider Trans	1.02%	Shs Float	37.53M	Perf Month	15.53%
Enterprise Value	375.67M	PEG	-	EPS next Q	-0.75	Inst Own	42.42%	Short Float	11.28%	Perf Quarter	27.97%
Income	-161.31M	P/S	-	EPS this Y	16.12%	Inst Trans	21.40%	Short Ratio	5.16	Perf Half Y	45.84%
Sales	0.00M	P/B	2.69	EPS next Y	2.51%	ROA	-53.64%	Short Interest	4.23M	Perf YTD	10.00%
Book/sh	3.85	P/C	2.24	EPS next 5Y	12.50%	ROE	-64.67%	52W High	13.67 -24.36%	Perf Year	390.05%
Cash/sh	4.61	P/FCF	-	EPS past 3/5Y	-75.86% -56.27%	ROIC	-62.68%	52W Low	2.05 404.39%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.13% 8.80%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-5.71%	Oper. Margin	-	ATR (14)	0.74	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	61.70	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.75	EPS Q/Q	7.59%	SMA20	10.09%	Beta	2.07	Target Price	29.60
Payout	-	Debt/Eq	0.12	Sales Q/Q	-	SMA50	16.07%	Rel Volume	1.58	Prev Close	9.35
Employees	130	LT Debt/Eq	0.11	Earnings	Mar 26 AMC	SMA200	43.71%	Avg Volume	820.61K	Price	10.34
IPO	Feb 08, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.99% -	Trades		Volume	1,295,761	Change	10.59%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)